Nonparticipation in a Population-Based Trial to Increase Colorectal Cancer Screening

被引:21
|
作者
Green, Beverly B. [1 ,2 ,3 ]
Bogart, Andy [1 ]
Chubak, Jessica [1 ]
Vernon, Sally W. [7 ]
Morales, Leo S. [1 ]
Meenan, Richard T. [8 ,9 ]
Laing, Sharon S. [5 ]
Fuller, Sharon [1 ]
Ko, Cynthia [4 ]
Wang, Ching-Yun [6 ]
机构
[1] Univ Washington, Grp Hlth Res Inst, Seattle, WA 98101 USA
[2] Univ Washington, Grp Hlth Permanente, Seattle, WA 98101 USA
[3] Univ Washington, Dept Family Med, Seattle, WA 98101 USA
[4] Univ Washington, Div Gastroenterol, Seattle, WA 98101 USA
[5] Univ Washington, Hlth Promot Res Ctr, Seattle, WA 98101 USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] Univ Texas Houston, Sch Publ Hlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA
[8] Ctr Hlth Res, Portland, OR USA
[9] Kaiser Permanente NW, Portland, OR USA
关键词
CLINICAL-TRIALS; UNDERREPRESENTED POPULATIONS; CARE; MANAGEMENT; INTERVENTION; RECRUITMENT; COMMUNITY; QUALITY; DESIGN; SYSTEM;
D O I
10.1016/j.amepre.2011.11.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Many trials have tested different strategies to increase colorectal cancer (CRC) screening. Few describe whether participants are representative of the population from which they are recruited. Purpose: To determine risk factors related to nonparticipation among patients enrolled in an integrated health plan and not up to date for CRC testing, in a trial to increase screening rates. Methods: Between July 2008 and October 2009, a total of 15,000 adults aged 50-74 years from 21 clinics in Washington State who were due for CRC screening were contacted. Nonparticipants were defined as English-speaking patients who did not engage in the call or refused participation while still potentially eligible. Log-binomial regression models were used to estimate the relative risk of nonparticipation. Analyses were completed between October 2010 and June 2011. Results: Patients who were nonwhite, had less education, used tobacco, had less continuity of care, and had lower rates of preventive care and cancer screening were more likely to be nonparticipants. Patients reporting never having received any type of CRC testing or screening were also more likely not to participate (62% of nonparticipants vs 46% of participants; adjusted RR = 1.58, 95% CI = 1.47, 1.70). Reasons for refusal included costs, risks of procedures, and not wanting their medical records reviewed. Conclusions: Patients eligible for but not participating in the trial were more likely to be from minority socioeconomic and racial groups and had behaviors that can negatively affect cancer outcomes. Additional efforts are needed to recruit patients who need CRC screening the most.
引用
收藏
页码:390 / 397
页数:8
相关论文
共 50 条
  • [1] Advance notification letters increase adherence in colorectal cancer screening: A population-based randomized trial
    van Roan, A. H. C.
    Hal, L.
    Wilschut, J. A.
    Reijerink, J. C. I. Y.
    van Vuuren, A. J.
    van Ballegooijen, M.
    Habbema, J. D. F.
    van Leerdam, M. E.
    Kuipers, Ernst J.
    [J]. PREVENTIVE MEDICINE, 2011, 52 (06) : 448 - 451
  • [2] Population-Based Colonoscopy Screening for Colorectal Cancer A Randomized Clinical Trial
    Bretthauer, Michael
    Kaminski, Michal F.
    Loberg, Magnus
    Zauber, Ann G.
    Regula, Jaroslaw
    Kuipers, Ernst J.
    Hernan, Miguel A.
    McFadden, Eleanor
    Sunde, Annike
    Kalager, Mette
    Dekker, Evelien
    Lansdorp-Vogelaar, Iris
    Garborg, Kjetil
    Rupinski, Maciej
    Spaander, Manon C. W.
    Bugajski, Marek
    Hoie, Ole
    Stefansson, Tryggvi
    Hoff, Geir
    Adami, Hans-Olov
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (07) : 894 - 902
  • [3] The case for population-based screening for colorectal cancer
    Robert E. Schoen
    [J]. Nature Reviews Cancer, 2002, 2 : 65 - 70
  • [4] The case for population-based screening for colorectal cancer
    Schoen, RE
    [J]. NATURE REVIEWS CANCER, 2002, 2 (01) : 65 - 70
  • [5] Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial
    Selva, A.
    Tora, N.
    Pascual, E.
    Espinas, J. A.
    Bare, M.
    [J]. COLORECTAL DISEASE, 2019, 21 (10) : 1120 - 1129
  • [6] A large population-based randomized controlled trial to increase attendance at screening for cervical cancer
    Eaker, S
    Adami, HO
    Granath, F
    Wilander, E
    Sparén, P
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (03) : 346 - 354
  • [7] Population-based screening for colorectal cancer in Wuhan, China
    Liu, Song
    Wang, Yifan
    Wang, Yuying
    Duan, Chaofan
    Liu, Fan
    Zhang, Heng
    Tian, Xia
    Ding, Xiangwu
    Zhang, Manling
    Cao, Dan
    Liu, Yi
    Jiang, Ruijingfang
    Zhuo, Duan
    Peng, Jiaxi
    Zhu, Shida
    Zhao, Lijian
    Wang, Jian
    Wei, Li
    Shi, Zhaohong
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [8] Cost-effectiveness of population-based screening for colorectal cancer
    J F O'Mahony
    [J]. British Journal of Cancer, 2013, 108 : 1209 - 1210
  • [9] Colorectal cancer screening attitudes and behavior: A population-based study
    Janz, NK
    Wren, PA
    Schottenfeld, D
    Guire, KE
    [J]. PREVENTIVE MEDICINE, 2003, 37 (06) : 627 - 634
  • [10] FACTORS ASSOCIATED WITH EFFECTIVENESS OF POPULATION-BASED COLORECTAL CANCER SCREENING
    Huang, R.
    Hsieh, K.
    Tarn, Y.
    Yang, Y.
    [J]. VALUE IN HEALTH, 2018, 21 : S11 - S11